PerkinElmer On R&D Expansion In Singapore: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
PerkinElmer expanded its R&D presence by opening a new Center of Excellence in Singapore March 26. PerkinElmer VP and Chief Scientific Officer Daniel Marshak talked with PharmAsia News from Singapore the following day about the expansion and the company's growing footprint in Asia. Marshak is responsible for setting the strategic direction of PerkinElmer's research and development functions. He joined the company in 2006, after serving as VP and chief technology officer of Cambrex Corp.
You may also be interested in...
PerkinElmer Expands Presence In Asia With Acquisition Of SYM-BIO
PerkinElmer's acquisition of Shanghai-based diagnostics company SYM-BIO for $63.7 million will enhance the firm's diagnostics market position in China
PerkinElmer Expands Presence In Asia With Acquisition Of SYM-BIO
PerkinElmer's acquisition of Shanghai-based diagnostics company SYM-BIO for $63.7 million will enhance the firm's diagnostics market position in China
Singapore Continues To Attract MNCs; Hill-Rom The Latest To Open Innovation Center In Country
SHANGHAI - Worldwide medical technology and device maker Hill-Rom opened its Asia-Pacific Innovation Center in Singapore Aug. 24. The new center will focus on research and development in micro-electronics and embedded software